DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
about
Desmosome regulation and signaling in diseaseDesmosomes in acquired diseaseMechanistic basis of desmosome-targeted diseasesCharacterization of desmoglein expression in the normal prostatic gland. Desmoglein 2 is an independent prognostic factor for aggressive prostate cancerPemphigus vulgaris antigen mRNA quantification for the staging of sentinel lymph nodes in head and neck cancer.Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis.Desmoglein 3, via an interaction with E-cadherin, is associated with activation of SrcLoss of the desmosomal cadherin desmoglein-2 suppresses colon cancer cell proliferation through EGFR signalingRole of human papillomavirus in oropharyngeal squamous cell carcinoma: A review.Desmocollin‑2 affects the adhesive strength and cytoskeletal arrangement in esophageal squamous cell carcinoma cellsUnimpaired skin carcinogenesis in Desmoglein 3 knockout mice.DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer.DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathwayCharacterization of full-length and proteolytic cleavage fragments of desmoglein-2 in native human colon and colonic epithelial cell lines.Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus VulgarisLoss of the p53/p63 target PERP is an early event in oral carcinogenesis and correlates with higher rate of local relapse.Desmosomes: a role in cancer?Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus mAb.Broken hearts, woolly hair, and tattered skin: when desmosomal adhesion goes awry.Desmosomes: new perpetrators in tumour suppressionGDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway.Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity.Cell-cell connectivity: desmosomes and disease.Beyond E-cadherin: roles of other cadherin superfamily members in cancer.Desmoglein 3: a help or a hindrance in cancer progression?150th Anniversary Series: Desmosomes and the Hallmarks of Cancer.Prognostic significance of DSG3 in rectal adenocarcinoma treated with preoperative chemoradiotherapy.Pathophysiology of the Desmo-Adhesome.Quantitative proteomic analysis of sphere-forming stem-like oral cancer cellsGrp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype.Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.RNAi-mediated inhibition of the desmosomal cadherin (desmoglein 3) impairs epithelial cell proliferation.Annexin A8 is a novel molecular marker for detecting lymph node metastasis in oral squamous cell carcinoma.The role of desmosomes in carcinogenesis.Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.Squamous cell carcinoma of the soft palate associated with autoantibodies to desmoglein 1 and 3.Determining the potential of desmoglein 3 as a sensitive and specific immunohistochemical marker for the detection of micrometastasis in patients with primary oral squamous cell carcinoma.Desmoglein-3/γ-catenin and E-cadherin/ß-catenin differential expression in oral leukoplakia and squamous cell carcinoma.Targeting DSG3: from pemphigus to squamous cell carcinoma.MiR-31-5p-ACOX1 Axis Enhances Tumorigenic Fitness in Oral Squamous Cell Carcinoma Via the Promigratory Prostaglandin E2.
P2860
Q27013675-98FF8246-943B-4202-8EB6-852A3B899BCAQ27025901-AB7DECAB-AF18-4CAA-9CEF-F9A77825A36AQ28295898-46B18D30-8DF9-4E8C-9FA5-5AABA673A5D0Q28539356-9550E1EE-A0E0-4B5B-98AF-B6D9BB98756EQ33620021-9203A319-DC67-4D06-8904-94A63A667D51Q33728014-13E91C1A-88F1-454C-B1CB-18A942A3CAD5Q33769643-D0CD334C-AC4A-40B0-ADA2-3CF9A7CCF34AQ33769890-7C54A35D-268D-4005-B55A-73798B91C998Q33770030-4100A4A9-F523-44C8-BEF6-AFE5B2D83B4AQ34426907-C3A4B45C-7162-4EC5-8B2B-BEB446607E2EQ34490907-4ED65F1E-5C9A-41FA-9E03-87F845F26C4FQ34727199-5CDB0BF9-3A28-4D2E-8C57-ABBC628E2F40Q34758600-919C6AAC-954A-465D-8821-D900C313D7E6Q35534067-670EEA65-D519-477E-BD5C-5870C1059086Q36052968-59524AEA-0920-48CA-8937-638C773A3AB6Q36469551-10FF7205-585A-4CA4-9D09-C1A233C30D97Q36829448-5CA14EC9-FB68-4E93-A77B-ECDEDCA204F9Q36927030-7B1EECE7-5FC4-4820-B466-EC5DF6A2840DQ36976907-ACF54A34-646E-44DA-94E6-76F2EBC75A75Q37237903-D9D740F3-5ECE-4EF0-B6B4-6B83C4A7CB28Q37702121-7323C67E-0D22-490F-9A32-F77EC832CFEBQ37750805-BDCCDB75-E1DB-4BCA-9F01-1143D1AEF04AQ37944471-028DF105-4904-40AE-A25E-B0F6814C16A7Q38179961-3E9E72FB-F9CD-4C74-93C6-4D0D599E43BFQ38335478-043501D3-C243-4E3D-BA52-DBA9BFFC9029Q38541665-128EE9CF-0B3E-4CF0-BB14-94ABA9667684Q38886547-3A22747D-371E-46AA-B7AC-09B8273891EEQ38922797-A041C5A2-08D3-4FF9-A73D-44DBADC24799Q39034542-D8E14877-B098-45E9-BCB3-2E60FDB249A2Q39066082-768C0D93-27FA-45D6-B321-FB3991AB0551Q39141633-14D0D8E7-DFB1-4DE6-96DF-C2B29B360F23Q39518667-5858319F-9B2D-478C-8972-F878BEB687E6Q39997881-BD26E775-B499-4477-8B46-41C9174A1D09Q41476742-CBE4C835-95DD-4E3D-8DF4-73FDEB7E57DFQ41974234-9990BFE0-B898-470A-B7C2-5EA4FC1FC669Q42133424-2D071DFC-163A-41B6-B626-73DF0D39F728Q42293421-FFEF2048-D8C8-476C-B9AC-5507E8198915Q44973022-107EF1F9-57F3-471F-98B6-DE2E8220862BQ45851388-B853D87C-0252-4218-8358-9A71AB4A524EQ47133718-A95E9014-561A-4EAF-9D84-9A17B9E3D0BC
P2860
DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
DSG3 is overexpressed in head ...... for inhibition of oncogenesis.
@en
type
label
DSG3 is overexpressed in head ...... for inhibition of oncogenesis.
@en
prefLabel
DSG3 is overexpressed in head ...... for inhibition of oncogenesis.
@en
P2093
P2860
P356
P1433
P1476
DSG3 is overexpressed in head ...... for inhibition of oncogenesis.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209802
P407
P577
2006-07-31T00:00:00Z
P5875
P6179
1046601885